Calorimetric and spectroscopic studies characterization of newborn rat’ blood serum after maternal administration of cyclophosphamide
- 514 Downloads
- 3 Citations
Abstract
Differential scanning microcalorimetry (DSC) and UV–VIS absorption spectroscopy were used to obtain the characteristics of blood serum from newborn rat’ after maternal treatment with cyclophosphamide in comparison with control. The obtained DSC curves reveal a complex endothermic peak due to the unfolding process of various serum proteins. Thermal profiles and absorption spectra of blood serum are sensitive to the age of newborns as well as to effect of maternal administration of cyclophosphamide. The most significant disturbances in serum proteome were observed for 14-day old newborns. The thermodynamic parameters: enthalpy change (∆H), the normalized first moment (M1) of the thermal transition with respect to the temperature axis and the ratio of C p ex at 70 and 60 °C describing denaturation contributions of globulin forms in respect to unliganded albumin with haptoglobin was estimated. Moreover, the second derivative spectroscopy in the UV region was used to resolve the complex protein spectrum. The differences in blood serum detected by DSC and UV–VIS confirm a potential usefulness of these methods for diagnostic and monitoring changes with age as well as the pathological state of blood serum.
Keywords
Blood serum Cyclophosphamide Differential scanning microcalorimetry Newborn rats UV–VIS spectroscopyIntroduction
Calorimetric techniques giving unique thermodynamic signature for individual proteins and binding interactions have become a useful method in the research of analytical medical problems such as degeneration of human cartilage [1] and muscle [2]. Special focus has been given to changes in blood serum [3, 4, 5].
It is thought that blood serum proteins make up 6–8% of the blood and are about equally divided between serum albumins and the great variety of serum globulins. Changes in concentration of blood serum proteins, their structure and binding properties can lead to pathological states such as cancer [6] and Alzheimer disease [7].
Cancer is one of the most common causes of death during the reproductive years [8]. When cancer occurs in pregnancy there is almost always a conflict between optimal maternal therapy and foetal well-being. Consequently, either maternal or foetal health or both may be endangered. If chemotherapeutic agents cross the placenta the foetus is exposed and this may lead to mutagenic effects especially to somatic cells, causing gene mutations and chromosomal breaks [9, 10]. Knowledge about the side effects resulting from the use of antineoplastic drugs during pregnancy is limited. Cyclophosphamide (CP) is an anti-cancer chemotherapy drug that is used primarily for treating several types of cancer, e.g., lymphoma, leukaemia, retinoblastoma, and cancers of the breast and ovary [11, 12]. This medication is classified as an “alkylating agent” and as D in the FDA pregnancy category, e.g., cyclophosphamide can be harmful to an unborn baby. CP may disturb normal growth and development by affecting protein degradation. Alkylation of neonatal proteins for example may alter the conformation of proteins thus rendering these molecules more susceptible to degradation [13].
This article describes the DSC and UV–VIS studies in vitro of newborn rat’s blood serum during the first month of life after maternal administration of CP.
Experimental
Materials
The experiments were carried out on blood serum obtained from Wistar newborn rats (6–7 rats in each group) whose mothers were fed a standard diet ad libitum. The rats were delivered by the Centre of Experimental Medicine of the Medical University of Silesia. The procedure of the experiments on animals was approved by the Local Ethics Commission in Katowice, Poland. Pregnant rats were obtained by caging a proestrus/oestrus female overnight with a male of proven fertility. Females showing a vaginal plug of the presence of spermatozoa in the vaginal smear were designated pregnant and housed in separate cages. The rats were divided into two groups. The first group of rats (CP group) received cyclophosphamide (Asta Medica) at a dose of 5 mg/kg ip. on 5, 10, and 15th day of pregnancy. The second group: the control female rats received 0.9% NaCl solution or water at the same volume of 2 or 1 mL/kg, respectively. The blood serum was obtained from 7-, 14- and 28-day old newborn rats. The samples were diluted 10-fold in degassed buffer KH2PO4/Na2HPO4 (Sigma–Aldrich) to the final pH equal 7.2. Protein concentration was determined according to its amount in dry mass of the serum sample.
Methods
Differential scanning calorimetry (DSC) scans were performed using the VP DSC ultrasensitive microcalorimeter (MicroCal Inc., Northampton, MA) with cell volumes of 0.5 mL. Heat capacity versus temperature profiles were obtained for scanning rate of 1.0 K min−1 in temperature range 25–100 °C. Additionally constant pressure of about 1.8 atm was exerted on the liquids in the cells. The calorimetric data were corrected for the instrumental baseline buffer–buffer. Samples were normalized for the gram mass of protein. A linear baseline was used to obtain the excess apparent molar heat capacity C p ex (J °C−1 g−1).
The DSC measurements were supported by optical spectroscopy. UV–VIS absorption spectra were obtained with the use of HR4000 spectrometer (Ocean Optics HR4C1970).
Analysis
DSC curves were analyzed with the use of MicroCal Origin and the UV–VIS spectra by means SpectraSiute software. Statistical analysis of the results was done with Statistica 7.1 using ANOVA. Schapiro-Wilk and Levene tests were performed to check the normality of the distributions and homogeneity of the variance, respectively. Differences with p < 0.05 were regarded as significant.
Results and discussion
Overall characteristics of the control group of newborns in relation to their age
Averaged absorption spectra of control blood serum for 7- and 28-day old newborn rats
The representative raw DSC curves of control blood serum from of 7- and 28-day old newborn rats
The comparison of thermodynamic parameters (temperature of peak maximum T m, calculated moments M1/°C and C p ex 70 /C p ex 60 (mean ± standard deviation)) of blood serum denaturation process as a function of rat’s age and maternal cyclophosphamide (CP) administration
| Days | Tm/°C | M1/°C | C p ex 70 /C p ex 60 | |||
|---|---|---|---|---|---|---|
| Control | CP | Control | CP | Control | CP | |
| 7 | 75.2 ± 0.3 | 75.1 ± 0.2 | 70.4 ± 0.1 | 69.9 ± 0.2 | 2.4 ± 0.2 | 1.8 ± 0.1 |
| 14 | 70.7 ± 0.2 | 76.0 ± 0.4 | 69.3 ± 0.3 | 73.2 ± 0.2 | 3.0 ± 0.1 | 9.0 ± 0.1 |
| 28 | 70.5 ± 0.2 | 67.5 ± 0.1 | 65.9 ± 0.9 | 67.1 ± 0.1 | 1.3 ± 0.2 | 1.6 ± 0.1 |
It should be noted that blood serum characteristics are influenced by the age of the newborns. There are large differences in DSC thermal transition profiles of blood serum from 7- and 28-days old newborns (Fig. 2). The change of the shape is accompanied by a marked shift of the main maximum towards lower temperatures with the age of the newborns (see also data in Table 1).The two weakly shaped local maxima at about 60 and 67 °C on the low temperature shoulder are also modified. The analysis of ratio C p ex70 /C p ex60 listed in Table 1 suggests that the albumin contributions are markedly bigger for 28-day newborns than for 7-day ones. This is in agreement with immunoelectrophoresis measurements which point to the increase of albumin and transferrin content with rat age [20]. The changing content of other constituents, e.g., various forms of globulins with rat age [21] cannot be neglected in factor C p ex70 /C p ex60 either.
Enthalpy change ΔH (mean and standard deviation) of blood serum for control and cyclophosphamide (CP) group as a function of a newborn rat’s age
Cyclophosphamide effect
DSC thermal transitions of blood serum from 7- (a), 14- (b), and 28-day old (c) newborn rats whose mothers were treated with cyclophosphamide (CP) in comparison with the control group. The shaded area is the standard deviation at each temperature. Inserts present differentiated curves between CP and the control groups
Special attention should be paid to the decomposition process of serum blood from 14-day newborn rats. An unexpected strong C p ex increase forming a double peak (at about 67 and 76 °C) (seen also in the differential curves) should be noted. There is an increase of amplitude of the peaks occurring at temperature above 65 °C with a concomitant decrease in amplitude of the local peak at about 60 °C. The ratio C p ex70 /C p ex60 indicates a large disturbance in the equilibrium of thermal denaturation of the individual proteins within serum.
Averaged absorption spectra of blood serum for control and cyclophosphamide (CP) group of 7-, 14-, 28-day old newborn rats
Our results demonstrate that maternal administration of CP causes statistically essential disturbance in enthalpy changes (∆H) (Fig. 3): an increase for 14- and decrease for 28-day rats in comparison with the control. Moreover, the values of the first moment (M1) of the thermal transition presented in Table 1 confirm the difference between the control and CP groups. For serum samples from 14-day rats increase of M1 is statistically essential and is still remarkable for the oldest newborns. It is noteworthy that the obtained values of M are close to the temperature of the peak maximum. It is dominated by globulin fractions and this fact suggests that these proteins are especially sensitive to CP administration as was previously mentioned in [23].
The UV–VIS spectral ratio A max/A min (A max local maximum at 278 nm, A min local minimum at 252 nm) for control and cyclophosphamide (CP) group as a function of newborn rat’s age
Second derivative of absorption spectra for blood serum from 28-day newborn rats for control and cyclophosphamide (CP) group
Conclusions
The obtained results have shown that the thermal transition of newborn rat’s blood serum proceed in the wide temperature range from 40 to 85 °C similarly as in human blood serum/plasma due to the analogous content of abundant serum proteins. However, the denaturation processes differ in their pathways. The heat effect from unfolding globulin forms seems to exceed that process connected with unliganded albumins. Thermal profiles and absorption spectra of blood serum are sensitive to the age of newborns as well as to effect of maternal administration of cyclophosphamide. The DSC measurements indicated the disturbance in the equilibrium of thermal denaturation of individual proteins within serum observed particularly in the case of samples from 14-day rats. It seems that the observed changes can be associated both with the alternation in protein content and the binding interactions in blood serum.
Our results confirm a potential usefulness of DSC and UV–VIS methods for diagnostic and monitoring changes with age as well as the pathological state of blood serum.
Notes
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
References
- 1.Sohár G, Pallagi E, Szabó-Révész P, Tóth K. New thermogravimetric protocol for the investigation of normal and damaged human hyaline cartilage. J Therm Anal Calorim. 2007;89:853–6.CrossRefGoogle Scholar
- 2.Wiegand N, Vamhidy L, Patczai B, Domse E, Kereskai L, Lorinczy D. Differential scanning calorimetric examination of the human skeletal muscle in a compartment syndrome of the lower extremities. J Therm Anal Calorim. 2009;98:177–82.CrossRefGoogle Scholar
- 3.Garbett NC, Mekmaysy CS, Helm W, Jenson AB, Chaires JB. Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol. 2009;86:186–91.CrossRefGoogle Scholar
- 4.Garbett NC, Millery JJ, Jenson AB, Chaires JB. Calorimetry outside the box: a new window into the plasma proteome. Biophys J. 2008;94:1377–83.CrossRefGoogle Scholar
- 5.Michnik A, Drzazga Z, Michalik K, Barczyk A, Santura I, Sozańska E, Pierzchała W. Differential scanning calorimetry study of blood serum in chronic obstructive pulmonary disease; 2010. doi: 10.1007/s10973-009-0602-6.
- 6.Pincus MR, Brandt-Rauf PW. Protein structure and cancer—cancer investigation. New York: Informa Healthcare; 1986. p. 185–95.Google Scholar
- 7.Lopez MF, Mikulskis A, Kuzdzal S, Bennett DA, Kelly J, Golenko E, DiCesare J, Denoyer E, Patton WF, Ediger R, Sapp L, Ziegert T, Lynch Ch, Kramer S, Whiteley GR, Wall MR, Mannion DP, della Cioppa G, Rakitan JS, Wolfe GM. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin Chem. 2005;51:101946–54.CrossRefGoogle Scholar
- 8.Kochanek, Murphy SL, Anderson RN, Scott C. National vital statistics report. 2004; p. 53.Google Scholar
- 9.Koren G, Lishner M, Farine D. Cancer in pregnancy: maternal and foetal risk. Cambridge: Cambridge University Press; 1996.CrossRefGoogle Scholar
- 10.Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7:394–403.CrossRefGoogle Scholar
- 11.Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice, 2nd edn. Lippincott-Raven, New York; Lippincott Williams & Wilkins; 2005.Google Scholar
- 12.Pratt WB, Ruddon RW. The anticancer drugs. Oxford: Oxford University; 1994.Google Scholar
- 13.Short R, Gibson J. Protein half-lives in neonatal mice after a toxic dose of cyclophosphamide. Cell Mol Life Sci. 1974;30:397–9.CrossRefGoogle Scholar
- 14.Raichenok TF. Luminescence of human blood serum in the longwave spectral region. J Appl Spectrosc. 1999;66:470–2.CrossRefGoogle Scholar
- 15.Mothé CG, Carestiato T, Águila MB. Thermoanalytical investigation of blood. J Therm Anal Calorim. 2006;2:247–51.CrossRefGoogle Scholar
- 16.Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins: II. Chemical and thermal stability. Pharm Res. 1998;15:449–54.CrossRefGoogle Scholar
- 17.Michnik A, Michalik K, Kluczewska A, Drzazga Z. Comparative DSC study of human and bovine serum albumin. J Therm Anal Calorim. 2006;84:113–7.CrossRefGoogle Scholar
- 18.Michnik A, Drzazga Z. Thermal denaturation of mixtures of human serum proteins. J Therm Anal Cal. 2010; doi: 10.1007/s10973-010-0826-5.
- 19.Michnik A, Drzazga Z, Michalik K, Kluczewska A. Differential scanning microcalorimetry study of the thermal denaturation of haemoglobin. Biophys Chem. 2005;118:93–101.CrossRefGoogle Scholar
- 20.Jordan SM, Morgan EH. Albumin, transferrin and gamma-globulin metabolism during lactation in the rat. Q J Exp Physiol Cogn Med Sci. 1967;52:422–9.Google Scholar
- 21.Heim WG. The serum proteins of the rat during development. J Embryol Exptl Morphol. 1961;9:52–9.Google Scholar
- 22.Dobrowolski P, Śliwa E. The weaning-related changes in amino acids status of blood plasma in piglets. J Pre-Clin Clin Res. 2008;2:071–4.Google Scholar
- 23.Mackiewicz U. Effects of cyclophosphamide on serum proteins in the rat. Acta Pol Pharm. 1967;24:549–53.Google Scholar
- 24.Artyukhov VG, Pantyavin AA, Vashanov GA. Vacuum-UV-radiation-induced structural-functional changes in serum albumin molecules. J App Spectrosc. 2001;68:291–8.CrossRefGoogle Scholar
- 25.Michnik A, Michalik K, Drzazga Z. Effect of UVC radiation on conformational restructuring of human serum albumin. J Photochem Photobiol B. 2008;90:170–8.Google Scholar
- 26.Balestrieri C, Colonna G, Giovane A, Irace G, Servillo L. Second-derivative spectroscopy of proteins: studies on tyrosyl residues. Eur J Biochem. 1978;90:433–40.CrossRefGoogle Scholar






